Market closed
ONKURE THERAPEUTICS INC/$OKUR
OnKure Therapeutics shares are trading lower after the company reported its Q1 results.
24 hours ago·Lightyear AI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About ONKURE THERAPEUTICS INC
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. The company operates in one operating segment which is clinical research. It has a pipeline of tumor-agnostic candidates that are designed to achieve optimal efficacy and tolerability.
Ticker
$OKUR
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
46
ISIN
US68277Q1058
Website
OKUR Metrics
BasicAdvanced
$27M
-
-$8.79
-
-
Price and volume
Market cap
$27M
52-week high
$18.23
52-week low
$1.98
Average daily volume
70K
Financial strength
Current ratio
11.175
Quick ratio
11.003
Long term debt to equity
0.451
Total debt to equity
1.054
Interest coverage (TTM)
-410.19%
Management effectiveness
Return on assets (TTM)
-61.00%
Return on equity (TTM)
-108.16%
Valuation
Price to book
0.3
Price to tangible book (TTM)
0.3
Growth
Earnings per share change (TTM)
223.13%
OKUR News
AllArticlesVideos
OnKure Therapeutics Reports First Quarter 2025 Financial Results and Business Highlights
GlobeNewsWire·4 days ago
OnKure Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
GlobeNewsWire·2 months ago
OnKure Therapeutics to Present at Upcoming Leerink and Stifel Investor Conferences
GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for ONKURE THERAPEUTICS INC stock?
ONKURE THERAPEUTICS INC (OKUR) has a market cap of $27M as of May 10, 2025.
What is the P/E ratio for ONKURE THERAPEUTICS INC stock?
The price to earnings (P/E) ratio for ONKURE THERAPEUTICS INC (OKUR) stock is 0 as of May 10, 2025.
Does ONKURE THERAPEUTICS INC stock pay dividends?
No, ONKURE THERAPEUTICS INC (OKUR) stock does not pay dividends to its shareholders as of May 10, 2025.
When is the next ONKURE THERAPEUTICS INC dividend payment date?
ONKURE THERAPEUTICS INC (OKUR) stock does not pay dividends to its shareholders.
What is the beta indicator for ONKURE THERAPEUTICS INC?
ONKURE THERAPEUTICS INC (OKUR) does not currently have a Beta indicator.